Showing 751-760 of 2652 results for "".
More Virtual CE Please
https://modernod.com/articles/significant-findings/more-virtual-ce-please/37761/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatProlonged Gaming and Dry Eye
https://modernod.com/articles/significant-findings/prolonged-gaming-and-dry-eye/37758/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatRyzumvi Rundown
https://modernod.com/videos/eye-care-insiders/eye-care-insiders-nov-2023-video/37334/Joseph J. Allen, OD, FAAO, Dipl ABO, spends this episode of Eye Care Insiders discussing phentolamine ophthalmic solution 0.75% (Ryzumvi, Ocuphire Pharma), explaining how it works, reviewing clinical trial findings, potential adverse events, how it could fit into your clinic, and more.Technology FTW
https://modernod.com/articles/significant-findings/technology-ftw/37755/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatConsiderations for Use of Two Newly Approved Drugs
https://modernod.com/podcasts/to-the-point/considerations-for-use-of-two-newly-approved-drugs/36928/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss factors to consider when bringing perfluorohexyloctane ophthalmic solution (Miebo, Bausch + Lomb) and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals) into your clinical practice.A New Perspective for To the Point
https://modernod.com/podcasts/to-the-point/a-new-perspective-for-to-the-point/36927/This month on To the Point, Jackie Garlich, OD, FAAO, introduces her new co-host, Jessilin Quint, OD, MS, MBA, FAAO. Dr. Quint shares her background and journey in optometry, including how she came to open her dry eye and aesthetics clinic 2 years ago in Maine.The Power of Personalization
https://modernod.com/topics/contact-lenses/the-power-of-personalization/38673/Tailoring eye wear recommendations to meet your patients’ individual needs can capture more patients with presbyopia and, in turn, boost your optical sales.Finally, a Treatment for Demodex Blepharitis
https://modernod.com/videos/eye-care-insiders/sl-are-you-prepared-to-treat-demodex-blepharitis-ph-heres-what-you-need-to-know-about-the-first-fda-approved-treatment-title-finally-a-treatment-for-demodex-blepharitis-the-first-fda-approved-treatment-for-idemodex-blepharitisi/37330/The first FDA-approved treatment for Demodex blepharitis has arrived, and Joseph J. Allen, OD, FAAO, Dipl ABO, reviews what you need to know to start using it in your clinic. He discusses the novel mechanism of action of lotilaner ophthalmic solution 0.25% (Xdemvy, formerly TP-03; Tarsus PharmaceutiEncourage Patients With DED to Examine Their Sleep Quality
https://modernod.com/articles/significant-findings/encourage-patients-with-ded-to-examine-their-sleep-quality/37748/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatPre-Surgery Checklist • Myopia Management • Externships
https://modernod.com/podcasts/the-mod-pod/pre-surgery-checklist-myopia-management-externships/36850/Comanaging patients undergoing refractive IOL surgery? M. Nabila Gomez, OD, FAAO, shares a pre-surgery checklist to ensure optimal results (00:56). If you manage patients with myopia, Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, reviews what myopia treatment options are available now and those likely to